Krebs Biochemicals & Industries Limited

NSE KREBSBIO.NS

Krebs Biochemicals & Industries Limited Return on Capital Employed (ROCE) for the year ending March 31, 2024: -12.93%

Krebs Biochemicals & Industries Limited Return on Capital Employed (ROCE) is -12.93% for the year ending March 31, 2024, a 25.08% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

Krebs Biochemicals & Industries Limited Return on Capital Employed (ROCE) for the year ending March 31, 2023 was -17.25%, a 50.74% change year over year.
Krebs Biochemicals & Industries Limited Return on Capital Employed (ROCE) for the year ending March 31, 2022 was -35.02%, a -76.12% change year over year.
Krebs Biochemicals & Industries Limited Return on Capital Employed (ROCE) for the year ending March 31, 2021 was -19.89%, a 21.42% change year over year.
Krebs Biochemicals & Industries Limited Return on Capital Employed (ROCE) for the year ending March 31, 2020 was -25.31%, a -60.77% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

NSE: KREBSBIO.NS

Krebs Biochemicals & Industries Limited

CEO	Mr. Jitendra Rameshchandra Shah
IPO Date	Oct. 27, 2016
Location	India
Headquarters	Maas Heights
Employees	191
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Clinical Trials Cosmetics Fertilizers

Description

Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is headquartered in Hyderabad, India.

Key trends

Past 5 years